Study# CRAD001HUS191T: Post-transplant NASH protocol to assess the development of metabolic co-morbidities and disease recurrence in those transplanted for NASH cirrhosis (CRAD001HUS191T)

Project: Research project

Project Details

StatusActive
Effective start/end date7/1/1812/31/21

Funding

  • Novartis Pharmaceuticals Corporation (CRAD001HUS191T)